The ACIP voted on a routine recommendation for these vaccines during their October meeting and if confirmed by the CDC Director, it will be published in the MMWR and incorporated into the 2022 CDC Immunization Schedule accordingly.
Publication of the updated vaccine schedule typically signals to the insurance companies to begin covering their administration to patients. As with any new vaccine, we recommend that our members confirm adequate reimbursement is in place with their major payers before administering to patients. For reimbursement questions, please refer to the following hotlines:
Merck: 877-VAX-MERCK
Pfizer: 866-744-3198